Tables
- TABLE 1
Microbiological and demographic characteristics of the patients enrolled in the study
Lab no. Diagnosis year Exclusion reason Sex Age years Region of isolation MDR/XDR-TB STR INH RMP EMB PZA AMI CAP ETI MOX OFL LIN KAN CIC PAS Cluster no. S199228 2014 M 42 LTV XDR R R R R R R R R R R S S S S 2014 No culture isolation M 43 LTV XDR R R R R R R R R R R S S S S 2014 Only LPA M 47 LTV MDR NA R R NA NA NA NA NA NA NA NA NA NA NA TB25429 2014 M 41 LTV MDR R R R R R S S R S S S S S S 6 P1595 2014 M 37 LTV MDR R R R S R S S R S S S S S S 1 P1279 2014 F 31 LTV MDR R R R R R S S R S S S R S S S207797 2014 M 53 LTV MDR R R R S R S S R S S S S S S 2 P1428 2014 M 48 LTV MDR R R R S R S S R S S S S S S 1 P1378 2014 M 50 LTV XDR R R R R R S S R R R S R S S 3 P163 2014 M 53 LTV XDR R R R R R R S R R R S R S S 3 TB24818 2014 F 32 LTV MDR R R R R S S S S S S S S S S 7 P291 2014 M 28 LTV MDR R R R R S S S S S S S S S S TB25274 2014 M 37 LTV XDR R R R R R S S R S R S R R S S211891 2014 M 36 LTV MDR R R R R S S S R S S S S S S 7 P1599 2014 M 43 LTV MDR R R R R S S S S S S S S S S 6 P187 2014 M 58 LTV MDR R R R R R S S R S S S S S S 2 P88 2014 M 63 North MDR R R R S S S S S S S S S S S 4 P423 2014 F 75 North MDR R R R S S S S S S S S S S S 4 P292 2014 F 41 North MDR R R R S S S S S S S S S S S 4 P1536 2014 M 23 North MDR R R R S S S S S S S S S S S 4 P729 2014 M 47 North MDR R R R S S S S S S S S S S S P356 2014 M 42 North MDR S R R S S S S S S S S S S S P92 2014 M 59 Centre MDR R R R S S S S R S S S S S S 2 P340 2014 M 48 Centre XDR R R R R S R S R S R S R S S 3 2015 Only LPA M 31 LTV MDR NA R R NA NA NA NA NA NA NA NA NA NA NA P2624 2015 M 28 LTV MDR R R R R S S S R S S S S S S 7 P1928 2015 M 61 LTV MDR R R R R R S S R S S S S S S 1 P1229 2015 M 39 LTV XDR R R R R R R R R R R S R S S 1 P1876 2015 M 55 LTV XDR R R R R R R S R R R S R S S 3 P1926 2015 M 52 LTV XDR R R R R R R R R R R S R S S 1 P2829 2015 M 44 LTV MDR S R R S S S S R S S S S S S 1 P2184 2015 M 75 LTV MDR R R R R R R R R S S S R S S 1 P1994 2015 M 41 LTV MDR R R R S R S S R S S S S S S 2 P2058 2015 M 57 LTV MDR R R R S R S S R S S S S S S TB24737 2015 M 44 LTV XDR R R R R R R R S R R S R S R P1585 2015 F 42 LTV MDR R R R R S S S R S S S S S S 3 P2354 2015 F 27 LTV MDR R R R R R R R S S S S R S S P2471 2015 M 34 LTV MDR R R R R S S S R S S S S S S 3 2015 Only LPA F 32 LTV MDR NA R R NA NA NA NA NA NA NA NA NA NA NA P884 2015 M 61 LTV MDR R R R S R S S R S S S S S S 2 P2579 2015 M 35 LTV MDR R R R R R S S R S S S S S S P2452 2015 M 57 North MDR R R R S S S S R S S S S S S 3 P982 2015 M 37 North MDR R R R R R S S S S S S S S S P1880 2015 M 58 North MDR R R R S S S S S S S S R S S P2353 2015 M 21 Island of Madeira MDR S R R R S S S R S S S S S S 5 P27 2015 M 44 Algarve MDR S R R S S S S R S S S S S S 2015 Only LPA M 39 Alentejo MDR NA R R NA NA NA NA NA NA NA NA NA NA NA S308144 2016 M 41 LTV XDR R R R R R R S R R R S R S S 3 S309968 2016 F 41 North MDR R R R S S S S S S S S S S S 4 S310368 2016 M 42 North XDR R R R R R R S R R R S R S S 3 S312205 2016 F 63 LTV MDR S R R S R R R R S S S R S S 1 S314371 2016 M 15 LTV MDR R R R R S S S R S S S S S S 6 S324134 2016 M 61 Centre MDR R R R R R S S S S S S R S S 2016 No culture isolation F 45 LTV MDR R R R R R NA NA NA NA NA NA NA NA NA S326551 2016 M 40 LTV MDR R R R R R S S S S S S S S S S327889 2016 F 22 LTV XDR R R R R R R S R R R S R S S 3 S320857 2016 M 43 LTV MDR R R R R R S S S S S S S S S S316569 2016 M 54 North MDR R R R S S R R S S S S R S S S326782 2016 M 62 North MDR R R R S S S S R S S S S S S 3 S340248 2016 M 20 LTV MDR R R R S R S S R S S S S S S 2 TB31393 2016 F 40 LTV MDR R R R S S S S S S S S S S S S332846 2016 M 70 Centre MDR R R R S R S S S S S S S S S S347401 2016 F 20 LTV MDR R R R R S S S R S S S S S S ACC 2016 F 40 LTV MDR R R R S R S S R S S S S S S 2 S333605 2016 M 62 North MDR R R R S S S S R S S S S S S 3 S348387 2016 M UNK Centre MDR S R R S S S S S S S S S S S S352139 2017 F 22 Centre MDR R R R R R S S S S S S S S S 6 S375001 2017 F 22 Centre MDR S R R R S S S R S S S S S S 5 S374686 2017 F 34 LTV MDR S R R R R S S R S S S S S S S381277 2017 M 30 North MDR R R R R S S S S S S S S S S TB33470 2017 M 52 LTV MDR S R R R R S S R S S S S S S 1 S389865 2017 F 59 North MDR R R R R R S S S S S S S S S S387683 2017 M 56 LTV XDR R R R R R R S R R R S R S S 3 S399045 2017 F 41 North MDR R R R S S S S R R R S S S S S396397 2017 M 51 LTV XDR R R R R R R R R S S S R S S 1 S399986 2017 M 58 LTV MDR R R R R S S S R R R S S S S 3 TB34192 2017 M 62 LTV MDR R R R S S S S R S S S S S S 2 2017 Only LPA M 54 North MDR NA R R NA NA NA NA NA NA NA NA NA NA NA MDR: multidrug-resistant; XDR: extensively drug-resistant; TB: tuberculosis; STR: streptomycin; INH: isoniazid; RMP: rifampicin; EMB: ethambutol; PZA: pyrazinamide; AMI: amikacin; CAP: capreomycin; ETI: ethionamide; MOX: moxifloxacin; OFL: ofloxacin; LIN: linezolid; KAN: kanamycin; CIC: cycloserine; PAS: para-aminosalicylic acid; M: male; F: female; LTV: Lisbon and Tagus Valley; R: resistant; S: sensitive; NA: not available; LPA: line-probe assay; UNK: unknown.
Vol 5 Issue 1
Table of Contents
Trends of multidrug-resistant tuberculosis clustering in Portugal
